Dimethyl Fumarate Induces Apoptosis via Inhibiting NF-κB and STAT3 Signaling in Adult T-cell Leukemia/Lymphoma Cells

Dimethyl Fumarate Induces Apoptosis via Inhibiting NF-κB and STAT3 Signaling in Adult T-cell Leukemia/Lymphoma Cells

BACKGROUND/AIM: Adult T-cell leukemia (ATL) is a peripheral T lymphocytic malignancy caused by human T-cell leukemia virus type 1 (HTLV-1) infection. Despite treatment that includes novel agents that have been developed, most of ATL patients relapse and acquire multidrug resistance. As a result, the...

Full description

Bibliographic Details
Main Authors:	Asano, K. (Author), Ito, S. (Author), Maeta, T. (Author), Sato, T. (Author)
Format:	Article
Language:	English
Published:	NLM (Medline) 2022
Subjects:	adult T-cell c-IAP2 Dimethyl fumarate leukemia lymphoma NF-κB STAT3
Online Access:	View Fulltext in Publisher

Similar Items

Fumaric Acid Esters Do Not Reduce Inflammatory NF-κB/p65 Nuclear Translocation, ICAM-1 Expression and T-Cell Adhesiveness of Human Brain Microvascular Endothelial Cells
by: Axel Haarmann, et al.
Published: (2015-08-01)

Effects of dimethyl fumarate on neuroprotection and immunomodulation
by: Albrecht Philipp, et al.
Published: (2012-07-01)

Dimethyl fumarate as a safe and effective therapy for recalcitrant psoriasis in comorbid patients
by: Martina Burlando, et al.
Published: (2021-10-01)

Regulatory Networks Involving STATs, IRFs, and NFκB in Inflammation
by: Ekaterini Platanitis, et al.
Published: (2018-11-01)

Dimethyl Fumarate and Its Esters: A Drug with Broad Clinical Utility?
by: Stephanie Kourakis, et al.
Published: (2020-10-01)

Utilization of dimethyl fumarate and related molecules for treatment of multiple sclerosis, cancer, and other diseases
by: Azzam Maghazachi, et al.
Published: (2016-07-01)

A Bibliometric Evaluation of the Top 100 Cited Dimethyl Fumarate Articles
by: Francisco Javier García-Fernández, et al.
Published: (2021-02-01)

Dimethyl fumarate titration for the systemic treatment of moderate-to-severe plaque psoriasis
by: Giovanna Malara, et al.
Published: (2021-05-01)

NF-κB in Hematological Malignancies
by: Véronique Imbert, et al.
Published: (2017-05-01)

Calming the (Cytokine) Storm: Dimethyl Fumarate as a Therapeutic Candidate for COVID-19
by: Cara A. Timpani, et al.
Published: (2021-12-01)

The Age-Related Efficacy of Dimethyl Fumarate and Natalizumab in the Real-World Management of Multiple Sclerosis
by: Roberto De Masi, et al.
Published: (2021-01-01)

Genetic Study of Severe Prolonged Lymphopenia in Multiple Sclerosis Patients Treated With Dimethyl Fumarate
by: Dipen Sangurdekar, et al.
Published: (2019-11-01)

Dimethyl fumarate abrogates dust mite‐induced allergic asthma by altering dendritic cell function
by: Anil K. Jaiswal, et al.
Published: (2019-09-01)

USE OF DIMETHYL FUMARATE IN THE TREATMENT OF MULTIPLE SCLEROSIS: CLINICAL AND ECONOMIC ANALYSIS
by: V. R. Mkrtchyan, et al.
Published: (2016-12-01)

Docoxahexaenoic Acid Induces Apoptosis of Pancreatic Cancer Cells by Suppressing Activation of STAT3 and NF-κB
by: Mirae Park, et al.
Published: (2018-11-01)

Lichen-Derived Depsides and Depsidones Modulate the Nrf2, NF-κB and STAT3 Signaling Pathways in Colorectal Cancer Cells
by: Katarzyna Papierska, et al.
Published: (2021-08-01)

NF-κB signaling and its relevance to the treatment of mantle cell lymphoma
by: Swathi Balaji, et al.
Published: (2018-06-01)

Dimethyl fumarate inhibits antibody-induced platelet destruction in immune thrombocytopenia mouse
by: Huan Tong, et al.
Published: (2021-08-01)

Real-World Safety and Effectiveness of Dimethyl Fumarate in Hispanic or Latino Patients with Multiple Sclerosis: 3-Year Results from ESTEEM
by: Angel Chinea, et al.
Published: (2020-05-01)

[Budget impact analysis of delayed-release dimethyl-fumarate in the treatment of relapsing-remitting multiple sclerosis in Italy]
by: Gianluca Furneri, et al.
Published: (2016-03-01)

Dimethyl fumarate attenuates reactive microglia and long-term memory deficits following systemic immune challenge
by: Hallel C. Paraiso, et al.
Published: (2018-03-01)

Papaver nudicaule (Iceland poppy) alleviates lipopolysaccharide-induced inflammation through inactivating NF-κB and STAT3
by: Jae-Hyeon Oh, et al.
Published: (2019-04-01)

Glatiramer Acetate, Dimethyl Fumarate and Monomethyl Fumarate Up-Regulate the Expression of CCR10 on the Surface of Natural Killer Cells and Enhance their Chemotaxis and Cytotoxicity. Implications for Cancer Immunotherapy
by: Azzam Maghazachi, et al.
Published: (2016-10-01)

Real-World Safety and Effectiveness of Dimethyl Fumarate in Black or African American Patients with Multiple Sclerosis: 3-Year Results from ESTEEM
by: Mitzi J. Williams, et al.
Published: (2020-05-01)

Anti-Inflammatory and Anti-Oxidant Effect of Dimethyl Fumarate in Cystic Fibrosis Bronchial Epithelial Cells
by: Onofrio Laselva, et al.
Published: (2021-08-01)

Exploring the Use of Dimethyl Fumarate as Microglia Modulator for Neurodegenerative Diseases Treatment
by: Maria Rosito, et al.
Published: (2020-08-01)

Altholactone Inhibits NF-κB and STAT3 Activation and Induces Reactive Oxygen Species-Mediated Apoptosis in Prostate Cancer DU145 Cells
by: Chunwa Jiang, et al.
Published: (2017-02-01)

Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways
by: José Esparza-López, et al.
Published: (2019-07-01)

Dimethyl Fumarate Induces Metabolic Crisie to Suppress Pancreatic Carcinoma
by: Kaiyuan Chen, et al.
Published: (2021-02-01)

Dimethyl fumarate ameliorates endotoxin-induced acute kidney injury against macrophage oxidative stress
by: Kejun Zhou, et al.
Published: (2021-01-01)

Potent inhibitory effect of terpenoids from Acanthopanax trifoliatus on growth of PC-3 prostate cancer cells in vitro and in vivo is associated with suppression of NF-κB and STAT3 signalling
by: Dongli Li, et al.
Published: (2015-05-01)

The Dimethyl Fumarate Experience: A Handy Drug With Broad Clinical Utility
by: Lorena Lorefice, et al.
Published: (2021-09-01)

Dimethyl itaconate protects against lipopolysaccharide-induced endometritis by inhibition of TLR4/NF-κB and activation of Nrf2/HO-1 signaling pathway in mice
by: Mingyue Xu, et al.
Published: (2020-09-01)

Increased multiple sclerosis disease activity in patients transitioned from fingolimod to dimethyl fumarate: a case series
by: Silvia Delgado, et al.
Published: (2021-02-01)

Clinical evaluation of dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis: efficacy, safety, patient experience and adherence
by: Narapureddy B, et al.
Published: (2019-10-01)

Lirioresinol B dimethyl ether inhibits NF-κB and COX-2 and activates IκBα expression in CCl4-induced hepatic fibrosis
by: Adeeb Shehzad, et al.
Published: (2020-02-01)

Prevention of Autoimmune Diabetes in NOD Mice by Dimethyl Fumarate
by: Shiri Li, et al.
Published: (2021-01-01)

Dopamine delays articular cartilage degradation in osteoarthritis by negative regulation of the NF-κB and JAK2/STAT3 signaling pathways
by: Wei Lu, et al.
Published: (2019-11-01)

Tryptanthrin Protects Mice against Dextran Sulfate Sodium-Induced Colitis through Inhibition of TNF-α/NF-κB and IL-6/STAT3 Pathways
by: Zheng Wang, et al.
Published: (2018-05-01)

Neuroprotection and immunomodulation by dimethyl fumarate and a heterologous fibrin biopolymer after ventral root avulsion and reimplantation
by: Paula R. G. Kempe, et al.